Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability
Nephrology,Volume 23, Issue 8, Page 798-799, August 2018.
Source: Nephrology - Category: Urology & Nephrology Authors: Shinya
Nakatani
,
Eiji
Ishimura
,
Yuri
Machiba
,
Ayumi
Nakatani
,
Kenta
Fujimoto
,
Hideki
Uedono
,
Yujiro
Okute
,
Akihiro
Tsuda
,
Katsuhito
Mori
,
Masanori
Emoto
,
Masaaki
Inaba Source Type: research
More News: Polycystic Kidney Disease | Urology & Nephrology